开云体育
DEPICT-1 and DEPICT-2 Investigators
All authors
About
Publications While At 开云体育
selected publications
Journal Article
Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes: pooled 52-week outcomes from the DEPICT-1 and -2 studies
.
Diabetes, Obesity & Metabolism.
2021
Contact
full name
DEPICT-1 and DEPICT-2 Investigators
Quick Info
Publications
Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
Collaboration
Co-author network
Map of science